Short Summary
Milliken And Company appealed the Assistant Controller's order refusing to grant an Indian patent application. The appellant argued that the Controller failed to consider a crucial expert statement by Dr. Nathan A Mehl. The High Court found merit in the appeal, holding that foreign decisions are not binding and directing the matter back for fresh consideration.
Detailed Summary
When a multinational innovator files for a patent in India, it expects the application to be judged on its own technical merits, not on the shadow of decisions made in foreign jurisdictions. Yet for Milliken and Company, a refusal order revealed a deeper problem: a critical expert statement was brushed aside without proper consideration. This case is a wake-up call for every founder and IP professional who assumes that expert evidence will be weighed fairly, regardless of who provides it.
Milliken and Company, a well-known global enterprise, found itself at odds with the Assistant Controller of Patents and Designs in India after its patent application was refused. The refusal hinged significantly on the treatment of an expert statement submitted by Dr. Nathan A. Mehl, whose technical opinion was central to establishing the invention's novelty and inventive step. Milliken contended that the Controller had failed to properly examine and consider this expert testimony before arriving at the decision to deny the patent. Aggrieved by the refusal order, Milliken escalated the matter by way of appeal, seeking judicial review of the Controller's reasoning and process.
Milliken's primary argument was straightforward but powerful: the Assistant Controller had disregarded a crucial piece of expert evidence. The statement by Dr. Nathan A. Mehl was, according to the appellant, instrumental in demonstrating the technical merits of the invention, and its dismissal without substantive engagement undermined the fairness of the entire examination process. On the other side, the Controller of Patents and Designs stood by the refusal order, with the implicit justification that the expert's affiliation with the applicant and the fact that similar evidence had been rejected by foreign patent offices were sufficient grounds to discount the statement. This created a legal friction centered on a fundamental question: can expert testimony be sidelined merely because of the expert's relationship with the applicant, or because a foreign office reached a different conclusion?
The High Court found merit in Milliken's appeal. The court made it clear that foreign decisions, while they may offer persuasive guidance, are not binding on Indian patent authorities. Each application must be evaluated on its own footing, with due consideration given to all evidence presented, including expert statements. The court held that the refusal could not be sustained merely because the expert was an employee of the applicant or because a foreign patent office had rejected similar evidence. Consequently, the matter was remanded back to the Controller for fresh consideration, with directions to properly evaluate the expert statement by Dr. Nathan A. Mehl and all other relevant materials before issuing a new order.
For founders, inventors, and IP professionals, this case delivers a critical lesson: expert evidence in patent proceedings must be evaluated on its substantive technical merits, not dismissed on procedural or prejudicial grounds. If your expert happens to be affiliated with your company, that alone is not a valid reason to reject their testimony. Likewise, a rejection by a foreign patent office does not automatically seal your fate in India. When filing patent applications, ensure that your expert declarations are robust, technically detailed, and clearly tied to the legal requirements of novelty and inventive step. And if a patent office refuses your application without properly engaging with your expert evidence, remember that judicial review is available to correct such procedural oversights.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court. Understanding the court's reasoning in Milliken And Company vs Controller Of Patents And Designs & Anr. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Ashim GhoshvsThe Controller Of Patents
The petitioner challenged the Controller's action of treating his patent application (No. 1350/DEL/2007) as 'Deemed to be Withdrawn'. The withdrawal was based on the assumption that the request for examination was not made within the prescribed period, despite the petitioner having filed Form-18 correctly and within the time limit. The court found that the clerical error in the covering letter did not invalidate the timely filing of the substantive examination request.
Natco Pharma LimitedvsUnion Of India & Ors.
Natco Pharma Limited filed a writ petition challenging an order by the Assistant Controller that refused its application seeking cross-examination during pre-grant opposition proceedings against Novartis A.G.'s patent application (No. 4412/DELNP/2007). The court ultimately disposed of the petition, allowing for procedural steps to be taken in the underlying opposition.
Hebei Hailan Bearing Manufacture Co. Ltd.vsM/S Pearl Bearing Co.
In this trademark dispute, the Delhi High Court addressed an application by the Plaintiff seeking disclosure of financial and import documents from the Defendant. While the Defendant argued that some information was confidential, the Court issued a conditional order. The Defendant must now file an affidavit detailing complete sale figures and submit all requested documents in a sealed cover for judicial review before they can be released to the Plaintiff.
Vifor (International) LtdvsAlembic Pharmaceuticals Limited
Vifor (International) Ltd filed a suit against Alembic Pharmaceuticals Limited seeking permanent injunction and damages for infringing Vifor's patent. The parties subsequently reached an amicable settlement on August 9, 2021.
Unilever Plc & Anr.vsVikas Sachdeva
Plaintiffs, Unilever Plc & Anr., filed an interim application seeking ad-interim reliefs in a suit for infringement of their registered trademarks and copyrights. Plaintiffs alleged that the defendant was clandestinely marketing and selling cosmetic preparations bearing counterfeit marks (LAKME, LAKME 9 to 5, LAKME EYECONIC) and infringing artworks. The court granted an interim order appointing an Additional Special Receiver to seize and seal the infringing goods.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.